Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2019 R21 RFA-CA-18-002 KEUNG, ALBERT NORTH CAROLINA STATE UNIVERSITY RALEIGH Intracellular CRISPR gRNA assembly for massively multiplexed; one pot; (epi)genetic screening Active
2018 R33 RFA-CA-17-011 JIANG, NING UNIVERSITY OF TEXAS, AUSTIN An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer Active
2022 R21 CA21-005 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions Active
2021 R33 RFA-CA-20-018 HANSEN, ANDERS SEJR MASSACHUSETTS INSTITUTE OF TECHNOLOGY Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer Active
2020 R21 RFA-CA-19-019 ALEXANDRAKIS, GEORGIOS UNIVERSITY OF TEXAS ARLINGTON Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy Active
2019 R21 RFA-CA-18-002 O'NEILL, RACHEL UNIVERSITY OF CONNECTICUT STORRS Development and Utilization of Splice-specific Antibodies Active
2022 R33 CA21-004 MOELLERING, RAYMOND E UNIVERSITY OF CHICAGO Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues Active
2022 R21 CA21-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies Active
2021 R33 RFA-CA-20-018 LIU, XUEFENG OHIO STATE UNIVERSITY Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics Active
2020 R33 RFA-CA-19-020 MATRIX BHATNAGAR, PARIJAT SRI INTERNATIONAL T-cell Biofactories For Targeting Extracellular Matrix Active
2019 R21 RFA-CA-18-002 MONTAGNA, CRISTINA ALBERT EINSTEIN COLLEGE OF MEDICINE Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions Active
2022 R21 CA21-003 YAKOVLEV, VLADISLAV V TEXAS ENGINEERING EXPERIMENT STATION Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy Active
2021 R44 PAR-18-303 HUNG, PAUL JU-SUNG COMBINATI, INC. Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring Active
2020 R33 RFA-CA-19-020 COOKS, ROBERT GRAHAM PURDUE UNIVERSITY Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies Active
2019 R33 RFA-CA-18-003 KETTENBACH, ARMINJA NADINE DARTMOUTH COLLEGE Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics Active
2022 R33 CA21-004 CHIU, BRIAN C-H UNIVERSITY OF CHICAGO A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research Active
2020 R21 RFA-CA-19-021 GUPTA, GAUTAM UNIVERSITY OF LOUISVILLE Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens Active
2019 R33 RFA-CA-18-003 CHEN, SIDI YALE UNIVERSITY Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers Active
2005 R21 RFA-CA-05-004 GASTON, SANDRA MARLENE BETH ISRAEL DEACONESS MEDICAL CENTER TISSUE PRINT MICROPEELS FOR MOLECULAR PROFILING CANCER Complete
2008 R21 RFA-CA-07-035 LU, HANG GEORGIA INSTITUTE OF TECHNOLOGY MICROFLUIDIC SYSTEM FOR HIGH-THROUGHPUT EVALUATION OF T CELL FUNCTIONALITY WITH H Complete
2011 R21 RFA-CA-10-005 STRAUSS, STEVEN H. COLORADO STATE UNIVERSITY NANOCAGED METAL TAGS IN MASSIVELY MULTIPLEXED LEUKEMIA BIOASSAY AND BEYOND Complete
2015 R21 RFA-CA-14-005 QIN, LIDONG METHODIST HOSPITAL RESEARCH INSTITUTE HIGH THROUGHPUT SINGLE-CELL PHENOTYPE ISOLATION BY PROTRUSION ANALYSIS CHIP (PAC) Complete
1999 R43 PAR-98-066 XANTHOPOULOS, KLEANTHIS G AURORA BIOSCIENCES CORPORATION ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS Complete
2001 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2004 R43 PAR-01-105 HEILIG, JOSEPH S SOMALOGIC, INC. APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT Complete
2007 R33 RFA-CA-07-016 MACBEATH, GAVIN HARVARD UNIVERSITY QUANTITATIVE INTERACTION NETWORKS FOR TYROSINE-PHOSPHORYLATED PROTEINS Complete
2010 R21 RFA-CA-09-008 MITRA, ROBI D WASHINGTON UNIVERSITY HIGHLY PARALLEL EDMAN SEQUENCING OF INDIVIDUAL PEPTIDE MOLECULES Complete
2014 R33 RFA-CA-13-002 LOEB, LAWRENCE A UNIVERSITY OF WASHINGTON VALIDATION AND ADVANCED DEVELOPMENT OF DUPLEX SEQUENCING Complete
2017 R33 RFA-CA-16-002 SINGH, ANKUR CORNELL UNIVERSITY LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics Complete
2021 R21 CA20-017 DI CARLO, DINO UNIVERSITY OF CALIFORNIA LOS ANGELES Lab on a particle technology for functional screening of therapeutic cells Complete
2001 R33 PAR-98-067 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER Complete
2003 R43 PAR-01-105 SHEN, LI SUPERARRAY BIOSCIENCE CORPORATION ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT Complete
2007 R21 RFA-CA-07-001 LINK, DARREN R RAINDANCE TECHNOLOGIES, INC. EXON SPECIFIC SEQUENCING OF WHOLE GENOMIC DNA Complete
2009 R42 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2013 R33 RFA-CA-12-003 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER ADVANCED DEVELOPMENT OF IMMUNO-MRM TECHNOLOGY TO ANALYZE ARCHIVED CANCER TISSUES Complete
2016 R44 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. Next-Generation Antibody Discovery and Development Technology Complete
2000 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2002 R43 PAR-01-105 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. RAPID MOLECULAR DETECTION OF PML/RARALPHA Complete
2006 R21 RFA-CA-06-003 CREWS, CRAIG M YALE UNIVERSITY ANALYSIS OF TUMORIGENIC SIGNALING PATHWAYS WITH PROTACS Complete
2009 R21 RFA-CA-08-006 KRON, STEPHEN J. UNIVERSITY OF CHICAGO IMAGING DNA DAMAGE DYNAMICS FOR DIAGNOSTICS, SCREENING AND TARGET DISCOVERY Complete
2012 R21 RFA-CA-12-004 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA DEVELOPMENT OF ROOM-TEMPERATURE STORAGE TECHNIQUE FOR PLASMA/SERUM BIOSPECIMENS Complete
2016 R21 RFA-CA-15-002 HAUN, JERED BRACKSTON UNIVERSITY OF CALIFORNIA-IRVINE TRANSFORMING FLUORESCENCE LIFETIME IMAGING MICROSCOPY INTO A FAST AND SIMPLE PLATFORM FOR HIGH-CONTENT MOLECULAR ANALYSIS Complete
2000 R21 PAR-99-100 CHURCHILL, GARY A JACKSON LABORATORY EXPERIMENTAL DESIGN & ANALYSIS FOR EXPRESSION MICROARRAY Complete
2002 R33 PAR-01-104 BEACHY, PHILIP A JOHNS HOPKINS UNIVERSITY GENOME-BASED TARGETING OF THE HEDGEHOG PATHWAY IN CANCER Complete
2000 R21 PAR-99-100 WANG, BINGHE NORTH CAROLINA STATE UNIVERSITY RALEIGH FLUORESCENT TAGS TARGETED ON CELL SURFACE CARBOHYDRATES Complete
2002 R33 PAR-01-104 WAGGONER, ALAN S CARNEGIE-MELLON UNIVERSITY NEAR IR FLUORESCENT PROBES/MOLECULAR ANALYSIS OF CANCER Complete
2005 R21 RFA-CA-05-004 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED CELL PREPARATION IN TUBES FOR 3D MICROSCOPY Complete
2008 R21 RFA-CA-07-035 EDWARDS, JEREMY S. UNIVERSITY OF NEW MEXICO SEQUENCING CHR. 6 IN MELANOMA PATIENTS Complete
2011 R21 RFA-CA-10-005 LAVIE, ARNON UNIVERSITY OF ILLINOIS AT CHICAGO ENZYME-DELIVERY SCAFFOLD TECHNOLOGY FOR TARGETED CANCER KILLING. Complete
2015 R21 RFA-CA-14-005 GERTZ, JASON UNIVERSITY OF UTAH DEVELOPMENT OF ENHANCER RNA-BASED BIOMARKERS IN FFPE TISSUE Complete

Pages